Topics

Adicet Bio raises $80mm via Series B round

15:40 EDT 3 Oct 2019 | Elsevier Business Intelligence

Adicet Bio Inc. (developing allogeneic cell therapies for cancer) raised $80mm in its Series B round. New investors aMoon2 Fu...

Original Article: Adicet Bio raises $80mm via Series B round

NEXT ARTICLE

More From BioPortfolio on "Adicet Bio raises $80mm via Series B round"

Quick Search

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...